Comparative histological studies of mechanically versus manually processed sheep intestines used to make natural sausage casings

Journal of Food Protection

Volumn 67, Issue 12, 2004, Pages 2747-2755

  Koolmees, P A ^a   Tersteeg, M H G ^a   Keizer, G ^a   Van Den Broek, J ^a   Bradley, R ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; AVES; BOVIDAE; BOVINAE; CAPRA HIRCUS; MELEAGRIS GALLOPAVO; OVIS ARIES;

EID: 10344227192     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-67.12.2747     Document Type: Article

References (35)

1. Sc in gut-associated lymphoid and nervous tissue of susceptible sheep from a Romanov flock with natural scrapie. J. Gen. Virol. 81:3115-3126.
2. Bradley, R. 2002 Report on the safety of sheep intestine and natural casings derived therefrom in regard to risks from animal TSE and BSE in particular. Report prepared for the TSE/BSE ad hoc group of the European Commission Scientific Steering Committee 7 May 2002. European Commission, Brussels.
3. Comer, P. 2002. Assessment of the risk of exposure to the BSE agent through the use of natural sausage casings. Research for European Natural Sausage Casing Association. DNV Consulting, London.
4. Comer, P., and R. Bradley. 2002. Note on weights of intestine in small ruminants and expected risk reduction. Report for European Natural Sausage Casing Association, Hamburg. 26 August 2002.
5. Dellmann, H. D. 1993. A textbook of veterinary histology. Williams & Wilkins, Baltimore.
6. Diem, K., and C. Lentner. 1975. Wissenschaftliche Tabellen, 7th ed. Thieme, Stuttgart, Germany.
7. Drury, R. A. B., and E. A. Wallington (ed.). 1980. Carlton's histological technique, p. 216. Oxford University Press, Oxford.
8. European Commission. 1997. Decision no. 97/534/EC of 30 July 1997 on the prohibition of the use of material presenting risks as regards transmissible spongiform encephalopathies. European Commission, Brussels.
9. European Commission. 2003. Regulation no. 1139/2003 of 27 June 2003 amending regulation (EC) no. 999/2001 of the European Parliament and of the Council as regards monitoring programmes and specified risk material. European Commission, Brussels.
10. European Commission Scientific Steering Committee. 1988. The risk of infection of sheep and goats with the bovine spongiform encephalopathy agent, adopted on 24-25 September 1998. Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
11. European Commission Scientific Steering Committee. 1999. Opinion on the human exposure risk (HER) via food with respect to BSE; adopted on 10 December 1999. Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
12. European Commission Scientific Steering Committee. 2000. Opinion on the estimated range of doses of BSE infectivity that may pose a risk to man (with emphasis to the oral route of exposure). Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
13. European Commission Scientific Steering Committee. 2001. Preemptive risk assessment should BSE in small ruminants be found under domestic conditions; adopted by the SSC at its meeting of 8-9 February 2001. Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
14. European Commission Scientific Steering Committee. 2002. Opinion on TSE infectivity distribution in ruminant tissues (state of knowledge); adopted by the SSC at its meeting of 10-11 January 2002. Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
15. European Commission Scientific Steering Committee. 2002. Complement to the SSC opinion of 4-5 April 2002 on safe sourcing of small ruminant materials (with special reference to safety with regard to BSE risks of sheep intestines and casings), adopted by the SSC at its meeting of 12-13 September 2002. Scientific Steering Committee, Directorate-General for Health and Consumer Protection (SANCO), Brussels.
16. Flint, F. O., and K. Pickering. 1984. Demonstration of collagen in meat products by an improved picro Sirius red polarisation method. Analyst 109:1505-1506.
17. Foster, J. D., D. W. Parnham, N. Hunter, and M. Bruce. 2001. Distribution of prion protein in sheep terminally affected with BSE following experimental oral transmission. J. Gen. Virol. 82:2319-2326.
18. Hadlow, W. J., R. C. Kennedy, and R. E. Race. 1982. Natural infection of Suffolk sheep with scrapie virus. J. Infect. Dis. 146:657-664.
19. Hadlow, W. J., R. C. Kennedy, R. E. Race, and C. M. Eklund. 1980. Virologic and neurologic findings in dairy goats affected with natural scrapie. Vet. Pathol. 17:187-199.
20. Heggebø, R., C. M. Press, G. Gunnes, K. I. Lie, M. A. Tranulis, M. Ulvund, M. H. Groschup, and T. Landsverk. 2000. Distribution of prion protein in the ileal Peyer's patch of scrapie-free lambs and lambs naturally and experimentally exposed to the scrapie agent. J. Gen. Virol. 81:2327-2337.
21. Hunter, N., J. Foster, A. Chong, S. McCutcheon, D. Parnham, S. Eaton, C. MacKenzie, and F. Houston. 2002. Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83:2897-2905.
22. International Natural Sausage Casing Association Scientific Working Group. 2004. Personal communication.
23. Ironside. J. 1999. nvCJD: exploring the limits of our understanding. Biologist 46:172-176.
24. Jeffrey, M., S. Martin, J. R. Thomson, W. S. Dingwall, I. Begara-McGorum, and L. Gonzalez. 2001. Onset and distribution of tissue PrP accumulation in scrapie-affected Suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies. J. Comp. Pathol. 125:48-57.
25. Jeffrey, M., S. Ryder, S. Martin, S. A. C. Hawkins, L. Terry, C. Berthelin-Baker, and S. J. Bellworthy. 2001. Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J. Comp. Pathol. 124:280-289.
26. Junqueira, L. C., and J. Carneiro. 1984. Functionele histologie. Wetenschappelijke Uitgeverij Bunge, Utrecht, The Netherlands.
27. Koolmees, P. A. 1997. Report on histological research, p. 32-44. In Final report P1: inventory. EU - CRAFT project BRE 2. CT 94. 1495: Improved treatment of natural sausage casings for quality improvement in automated stuffing processes. Deutches Institut für Lebensmitteltechnik eV, Quackenbrück, Germany.
28. Koolmees, P. A., B. R. Berends, and M. H. G. Tersteeg. 2002. Risk assessment of the use of sheep natural casings and legs of lamb. Pilot research for the European Natural Sausage Casing Association, International Natural Sausage Casing Association, and North American Natural Casing Association. VVDO report no. 0204. Department of the Science of Food Animal Origin (VVDO), Utrecht University, Utrecht, The Netherlands.
29. Koolmees, P. A., and J. H. Houben. 1997. Inventory part: histology and microbiology of hog and sheep casings. Color print leaflet EU - CRAFT Project BRE 2. CT 94. 1495: Improved treatment of natural sausage casings for quality improvement in automated stuffing processes. Deutches Institut für Lebensmitteltechnik eV, Quackenbrück, Germany.
30. Krölling, O., and H. Grau. 1960. Lehrbuch der Histologie und der vergleichenden mikroskopischen Anatomie der Haustiere. Paul Parey, Berlin.
31. Pawitan, Y. 2000. In all likelihood. Statistical modelling and inference using likelihood. Oxford University Press, Oxford.
32. Russ, J. C. 1990. Computer-assisted microscopy. The measurement and analysis of images. Plenum Press, New York.
33. Van Keulen, L. J. M., B. E. C. Schreuder, M. E. W. Vromans, J. P. M. Langeveld, and M. A. Smits. 1999. Scrapie-associated prion protein in the gastro-intestinal tract of sheep with natural scrapie. J. Comp. Pathol. 121:55-63.
34. Van Keulen, L. J. M., M. W. Vromans, and F. G. Zujderveld. 2002. Early and late pathogenesis of natural scrapie infection in sheep. APMIS 110:23-32.
35. World Health Organization. 2003. WHO guidelines on transmissible spongiform encephalopathies in relation to biological and pharmaceutical products. WHO/BCT/QSD/03.01, p. 26. World Health Organization, Geneva.